SOURCE: Xtalks

Xtalks Webinars

August 24, 2016 07:00 ET

Conclusive Results: Strategies for Collecting Quality Data in Psychiatric Clinical Trials, New Webinar Presented by Premier Research and Hosted by Xtalks

TORONTO, ON--(Marketwired - August 24, 2016) -

During this webinar, industry experts Krista Armstrong, Vice President of Strategic Development and Susan Kozauer, Senior Medical Director of Psyciantry, both from Premier Research, will examine factors that produce a therapeutic effect which erodes the efficacy signal of a potential treatment, with particular focus on study design considerations, site factors, subject selection and eligibility, and data surveillance. The live broadcast takes place on Tuesday, September 20, 2016 at 11am EDT (4pm BST/UK).

Ensuring that psychiatry clinical trial data accurately captures a compound's safety and efficacy potential requires an approach that accounts for challenges inherent in working with a mentally ill population. Observing changes in the disease under study is partly a subjective process, and that creates risk of undue influence that the patient and/or investigator may not recognize.

Additionally, not all symptomatic improvement in mental disorders is necessarily attributable to the product under study. Some may result from unrelated factors that produce a therapeutic effect eroding the efficacy signal of a potential treatment. These are among many issues that, if identified and mitigated early in the development process, can maximize the potential for conclusive study results.

For more information or to register for this complimentary webinar visit: Conclusive Results: Strategies for Collecting Quality Data in Psychiatric Clinical Trials

About Premier Research

Premier Research is a leading contract research organization serving the needs of biotechnology, pharmaceutical, and medical device companies worldwide. The company has a wealth of experience in the execution of global, regional, and local clinical development programs, with a special focus on addressing unmet needs in areas such as analgesia, CNS, rare diseases, medical device and diagnostics, oncology, and pediatric research. Premier Research operates in 84 countries and employs more than 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. With its mission to improve productivity in clinical development, the company aligns itself with the mission of its customers to bring new medical treatments to patients promptly, accurately, and cost-effectively.

To learn more about Premier Research visit: premier-research.com

About Xtalks

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2016/8/23/11G111576/Images/Premier_Research_logo-398906951265.jpg

Contact Information